Dad-of-three Ross Welsh was diagnosed with a grade 2 glioma in July this year, aged 40, after suffering a seizure while asleep. He underwent surgery in August to remove the 2.5cm tumour but was told that some cells remained, meaning further growth could develop in the future.
Ross has just started a new targeted treatment, vorasidenib which was approved for use on the NHS for eligible patients with certain types of low-grade glioma earlier this year. Vorasidenib was shown in trials to prolong progression-free survival, lengthening the time patients could go before requiring chemotherapy or radiotherapy.
Ross said: “I feel very fortunate to be able to benefit from this new treatment, even if I do need radiotherapy further down the line.
“My life as a husband, dad and qualified financial advisor changed in an instant with my diagnosis. Now I’m supporting a cause that is close to my heart.
“I signed up to take on 99 Miles in November for Brain Tumour Research because it feels important to me to help fund the research to discover and develop new treatments.”
Inspired by Ross’s story? There’s still time to join 99 Miles in November and help power life-changing research and campaigning to find a cure for brain tumours.
Choose how you move, whether that’s walking, jogging, running, cycling, swimming or even horse riding and complete 99 miles throughout November in a way that suits you. You can aim for 3.3 miles a day or spread your miles across the month to fit with your lifestyle. Every mile covered and every pound raised brings us closer to new treatments and ultimately a cure for brain tumours. Sign up to the challenge here.
Related reading:
